Osteoarthritis and Cartilage
Volume 18, Issue 3 , Pages 303-311 , March 2010

Development of a population-based microsimulation model of osteoarthritis in Canada

  • J.A. Kopec

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • Corresponding Author InformationAddress correspondence and reprint requests to: J. A. Kopec, School of Population and Public Health, University of British Columbia, Research Scientist, Arthritis Research Centre of Canada, 895 West 10th Avenue, Vancouver, BC V5Z 1L7, Canada. Tel: 1-604-871-4588; Fax: 1-604-879-3791.
    • ,
  • E.C. Sayre

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • W.M. Flanagan

      Affiliations

    • Statistics Canada, Ottawa, ON, Canada
    • ,
  • P. Fines

      Affiliations

    • Statistics Canada, Ottawa, ON, Canada
    • ,
  • J. Cibere

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • Md.M. Rahman

      Affiliations

    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • N.J. Bansback

      Affiliations

    • Centre for Health Economics and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada
    • ,
  • A.H. Anis

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • Centre for Health Economics and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada
    • ,
  • J.M. Jordan

      Affiliations

    • University of North Carolina, Chapel Hill, NC, USA
    • ,
  • B. Sobolev

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • ,
  • J. Aghajanian

      Affiliations

    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • W. Kang

      Affiliations

    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • N.V. Greidanus

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • D.S. Garbuz

      Affiliations

    • University of British Columbia, Vancouver, BC, Canada
    • Arthritis Research Centre of Canada, Vancouver, BC, Canada
    • ,
  • G.A. Hawker

      Affiliations

    • University of Toronto, Toronto, ON, Canada
    • ,
  • E.M. Badley

      Affiliations

    • University of Toronto, Toronto, ON, Canada

Received 4 April 2009 ,Accepted 15 October 2009.

References 

  1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–799
  2. Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;33(8):635–646
  3. Kopec JA, Rahman MM, Sayre EC, Cibere J, Flanagan WM, Aghajanian J, et al. Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996–1997 through 2003–2004. Arthritis Rheum. 2008;59(7):929–934
  4. Badley EM, Wang PP. Arthritis and the aging population: projections of arthritis prevalence in Canada 1991–2031. J Rheumatol. 1998;25(1):138–144
  5. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006;54(1):226–229
  6. Perruccio AV, Power JD, Badley EM. Revisiting arthritis prevalence projections–it's more than just the aging of the population. J Rheumatol. 2006;33(9):1856–1862
  7. Woolf AD. The bone and joint decade. Strategies to reduce the burden of disease: the Bone and Joint Monitor Project. J Rheumatol Suppl. 2003;67:6–9[Review]
  8. Bijlsma JW, Knahr K. Strategies for the prevention and management of osteoarthritis of the hip and knee. Best Pract Res Clin Rheumatol. 2007;21(1):59–76
  9. Vignon E, Valat JP, Rossignol M, Avouac B, Rozenberg S, Thoumie P, et al. Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS). Joint Bone Spine. 2006;73(4):442–455
  10. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162
  11. Arthritis Foundation, Association of State and Territorial Health Officials, Centers for Disease Control and Prevention. National Arthritis Action Plan. A Public Health Strategy. 1999. Internet address. http://ww2.arthritis.org/resources/ActionPlanInterior.pdf[accessed 20.01.09]
  12. Lohmander LS, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Engström G. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass. A population-based prospective cohort study. Ann Rheum Dis. 2009;68(4):490–496
  13. Luo W, Morrison M, de Groh M, Waters C, DesMeules M, Jones-McLean E, et al. The burden of adult obesity in Canada. Chronic Dis Can. 2007;27(4):135–183
  14. Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. The causes and effects of socio-demographic exclusions from clinical trials. iii–iv, ix–x Health Technol Assess. 2005;9(38):1–152
  15. Andrews G, Simonella L, Lapsley H, Sanderson K, March L. Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis. J Rheumatol. 2006;33(4):671–680
  16. Segal L, Day SE, Chapman AB, Osborne RH. Can we reduce disease burden from osteoarthritis? An evidence-based priority-setting model. Med J Aust. 2004;180(Suppl 5):S11–S17
  17. Fone D, Hollinghurst S, Temple M, Round A, Lester N, Weightman A, et al. Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med. 2003;25(4):325–335
  18. Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics. 2006;24(11):1043–1053
  19. Feuer EJ, Etzioni R, Cronin KA, Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004;13(6):421–442
  20. Brown JB, Russell A, Chan W, Pedula K, Aickin M. The global diabetes model: user friendly version 3.0. Diabetes Res Clin Pract. 2000;50(Suppl 3):S15–S46
  21. Le Lay A, Despiegel N, Francois C, Duru G. Related Articles. Can discrete event simulation be of use in modelling major depression?. Cost Eff Resour Alloc. 2006;5(4):19–30
  22. Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, et al. An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists. Drugs. 2005;65(4):473–496
  23. Marshall JK, Pellissier JM, Attard CL, Kong SX, Marentette MA. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario ministry of health perspective. Pharmacoeconomics. 2001;19(10):1039–1049
  24. Zabinski RA, Burke TA, Johnson J, Lavoie F, Fitzsimon C, Tretiak R, et al. An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada. Pharmacoeconomics. 2001;19(Suppl 1):49–58
  25. Haglund U, Svarvar P. The Swedish ACCES model: predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis. Rheumatology (Oxford). 2000;39(Suppl 2):51–56
  26. Chancellor JV, Hunsche E, de Cruz E, Sarasin FP. Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor. Pharmacoeconomics. 2001;19(Suppl 1):59–75
  27. Maetzel A, Krahn M, Naglie G. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Rheum. 2003;49(3):283–292
  28. Will BP, Berthelot J-M, Nobrega KM, Flanagan W, Evans WK. Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. Eur J Cancer. 2001;37(14):1797–1804
  29. Wolfson MC. POHEM—a framework for understanding and modelling the health of human populations. World Health Stat Q. 1994;47(3–4):157–176
  30. Law A, Kelton WD. Simulation Modeling and Analysis. 3rd edn. McGraw-Hill; 1999;
  31. In:  Gupta A,  Harding A editor. Modeling Our Future. Population Aging, Health and Aged Care. Amsterdam: Elsevier; 2007;
  32. Will BP, Le Petit C, Berthelot J-M, Tomiak EM, Verma S, Evans WK. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs. Br J Cancer. 1999;79(9–10):1428–1436
  33. Will BP, Nobrega KM, Berthelot J-M, Flanagan W, Wolfson MC, Logan DM, et al. First do no harm: extending the debate on the provision of preventive tamoxifen. Br J Cancer. 2001;85(9):1280–1288
  34. Evans WK, Will BP, Berthelot J-M, Logan DM, Mirsky DJ, Kelly N. Breast cancer: better care for less cost: is it possible?. Int J Technol Assess Health Care. 2000;16(4):1168–1178
  35. Will BP, Berthelot J-M, Le Petit C, Tomiak E, Verma S, Evans WK. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer. 2000;36(6):724–735
  36. Berthelot J-M, Will BP, Evans WK, Coyle D, Earle CC, Bordeleau L. Decision framework for chemotherapeutic interventions for metastatic non-small cell lung cancer. J Natl Cancer Inst. 2000;92(16):1321–1329
  37. Flanagan W, Le Petit C, Berthelot J-M, White KJ, Coombs BA, Jones-McLean E. Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can. 2003;24(4):81–88
  38. Maroun J, Ng E, Berthelot J-M, Le Petit C, Dahrouge S, Flanagan WM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can. 2003;24(4):91–101
  39. Statistics Canada. Canadian Community Health Survey (CCHS) Cycle 1.1 Internet address, http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SurvId=3226&SurvVer=0&InstaId=15282&InstaVer=1&SDDS=3226&lang=en&db=imdb&adm=8&dis=2. [accessed: 20.01.09]
  40. George MV, Loh S, Verma RBP, Shin YE. Population Projections for Canada, Provinces and Territories 2000–2026. Statistics Canada, Demography Division. Catalogue no. 91-520-XPB ISBN 0-660-60634-8 Ministry of Industry; 2001;
  41. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham study. Ann Intern Med. 1988;109(1):18–24
  42. Statistics Canada. National Population Health Survey (NPHS) Internet address. http://www.statcan.ca/english/concepts/nphs/Last updated: 2004-08-20
  43. National Population Health Survey, Cycle 6 Synthetic Master File, 2007. Statistics Canada. Health Statistics Division. Internet address http://data.library.ubc.ca/java/jsp/database/production/detail.jsp?id = 1092
  44. Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB. Creating a population-based linked health database: a new resource for health services research. Can J Public Health. 1998;89(4):270–273
  45. Kopec JA, Rahman MM, Berthelot JM, Le Petit C, Aghajanian J, Sayre EC, et al. Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol. 2007;34(2):386–393
  46. Bedson J, Mottram S, Thomas E, Peat G. Knee pain and osteoarthritis in the general population: what influences patients to consult?. Fam Pract. 2007;24(5):443–453
  47. Flanagan WM, Kopec JA, Finès P, Rahman MM, Sayre EC, Cibere J, et al. Estimating prevalence of physician-diagnosed osteoarthritis in Canada using microsimulation. (Abstract) Osteoarthritis Cartilage. 2008;16(Suppl 4):S153
  48. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–128
  49. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9(8):901–910
  50. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995;38(8):1134–1141
  51. Wilkins K. Incident arthritis in relation to excess weight. Health Rep. 2004;15:39–49
  52. Rahman MM, Aghanjanian J, Kopec JA, Cibere J. Validation of osteoarthritis diagnosis in administrative data using a clinically and radiologically defined population-based cohort of osteoarthritis. (Abstract) Osteoarthritis Cartilage. 2008;16(Suppl 4):S150
  53. Harrold LR, Yood RA, Andrade SE, Reed JI, Cernieux J, Straus W, et al. Evaluating the predictive value of osteoarthritis diagnoses in an administrative database. Arthritis Rheum. 2000;43(8):1881–1885
  54. Schultz SE, Kopec JA. Impact of chronic conditions. Health Rep. 2003;14(4):41–53
  55. Kopec JA, Finès P, Flanagan WM, Sayre EC, Rahman M, Bansback N, et al. Projecting the burden of osteoarthritis in Canada using microsimulation. (Abstract) Ann Rheum Dis. 2009;68(Suppl 3):99
  56. Finès P, Flanagan W, Kopec JA, Rahman MM, Sayre EC, Cibere J, et al. Projecting number of osteoarthritis patients from 2001 to 2021 in Canada using microsimulation. (Abstract) Arthritis Rheum. 2007;56(Suppl 9):S341

PII: S1063-4584(09)00282-9

doi: 10.1016/j.joca.2009.10.010

Osteoarthritis and Cartilage
Volume 18, Issue 3 , Pages 303-311 , March 2010

Article Tools

* Image Usage & Resolution